New York, NY, November 19, 2009-Ebitda News reports that EBITDA for Medicis Pharmaceutical Corporation (NYSE:MRX) for its quarter ended September 30, 2009 was $38,930,000, a 51% increase over the year ... read full story
Stocks ended flat and closed July with the strongest monthly gains in a year. The markets were volatile throughout the session following mixed economic data earlier. Recovery concerns were renewed after GDP growth slowed in Q2, but Chicago PMI jumped ... read full story